Does VINORELBINE Cause Diffuse large b-cell lymphoma recurrent? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with VINORELBINE (Vinorelbine). This represents 0.5% of all adverse event reports for VINORELBINE.
25
Reports of Diffuse large b-cell lymphoma recurrent with VINORELBINE
0.5%
of all VINORELBINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From VINORELBINE?
Of the 25 reports, 4 (16.0%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which VINORELBINE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A